A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine
Judy Illes, Douglas Sipp, Erika Kleiderman and 11 more
npj Regenerative Medicine · 2017
doi:10.1038/s41536-017-0026-z (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Regenerative medicine has attracted the interest of scientists, physicians, and patient communities, and as well as policy-makers and the broader public given related ethical, legal, and social implications. Here we examine past initiatives in the ethical, legal and social implications arena in regenerative medicine, and offer our views on actionable priorities for the future in six key areas: capacity building, policy, engagement with industry, resaerch ethics, communication, and community building.
Abstract licence: CC BY-NC-ND
References19
19 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.